Form 4: Nuvalent Director Andrew Hack Sells Shares in Multiple Transactions

Andrew Hack, a director at Nuvalent, Inc., sold a significant number of Class A Common Stock shares in multiple transactions on March 27, 2024.

Summary

• On March 27, 2024, Andrew Hack, a director of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed in multiple transactions with prices ranging from $76.46 to $77.44 per share for one set of transactions and at $72.31 for another set.
• A total of 88,205 shares were sold at a weighted average price of $76.8807.
• Additionally, 791,795 shares were sold at $72.31.
• Following these transactions, Andrew Hack indirectly owns 2,697,267 shares through Bain Capital Life Sciences Entities.
• Hack disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales by a director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of stock sales by a company insider, which is common in the biotech industry. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The sale of shares by a director could potentially create short-term uncertainty among shareholders.
• However, the filing indicates that Hack still indirectly owns a significant number of shares, suggesting continued alignment with the company's success.

Key Dates